Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Tuy nhin vn cn phi tham kho kin ca bc s nu 2 i tng ny c nhu cu s dng
2284-C CHARACTERIZING DEVELOPMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE IN HUMAN PRECISION-CUT LIVER SLICES Mei Li 1 , Vincent De Meijer 2 , Anika Nagelkerke 1 and Peter Olinga 1 , (1)University of Groningen, (2)University Medical Center Groningen Background: Non-alcoholic fatty liver disease (NAFLD) is a growing healthcare problem, ranging from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH) and often leading to fibrosis and cirrhosis along with hepatocellular carcinoma
Rogal 2,6 , (1)University of Pittsburgh Medical Center, (2)VA Pittsburgh Healthcare System, (3)Veterans Integrated Service Network 20, (4)VA Long Beach Healthcare System, (5)Virginia Commonwealth University and Central Virginia Veterans Healthcare System, (6)University of Pittsburgh, (7)VA Ann Arbor Healthcare System, (8)University of Michigan Background: The COVID-19 pandemic has accelerated an already increasing prevalence of alcohol use disorder (AUD) and caused disruptions in already low rates of AUD adoption, particularly for women
It helps control blood sugar and lower A1C levels
Why Medical Supervision Is Essential for Safety This is where having a professional in your corner makes all the difference
Helpful information about GLP-1 Probiotic PRO Increases GLP-1 naturally * *Based on preclinical studies Formulated with: Akkermansia muciniphila generates the postbiotics propionate and p9 which induce GLP-1 production
US$ 27.74
US$ 23.10
US$ 28.33
US$ 27.48
US$ 21.54
